Mesoblast
MESO
#4332
Rank
$2.41 B
Marketcap
$18.76
Share price
3.59%
Change (1 day)
73.06%
Change (1 year)

Revenue for Mesoblast (MESO)

Revenue in 2022: $7.81 Million USD

According to Mesoblast 's latest financial reports the company's current revenue (TTM ) is $7.65 Million USD. In 2022 the company made a revenue of $7.81 Million USD a decrease over the revenue in the year 2021 that were of $9.88 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Mesoblast from 2015 to 2022

Annual revenue

Year Revenue Change
2022$7.81 M-20.97%
2021$9.88 M-39.41%
2020$16.31 M-22.8%
2019$21.13 M33%
2018$15.88 M-0.43%
2017$15.95 M-49.9%
2016$31.84 M33.08%
2015$23.93 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
$0.13 B 1,717.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas